SI-BONE Statistics
Total Valuation
SI-BONE has a market cap or net worth of $702.88 million. The enterprise value is $590.60 million.
Important Dates
The next estimated earnings date is Monday, February 24, 2025, after market close.
| Earnings Date | Feb 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SI-BONE has 41.94 million shares outstanding. The number of shares has increased by 11.42% in one year.
| Current Share Class | 41.94M |
| Shares Outstanding | 41.94M |
| Shares Change (YoY) | +11.42% |
| Shares Change (QoQ) | +0.97% |
| Owned by Insiders (%) | 2.58% |
| Owned by Institutions (%) | 90.18% |
| Float | 37.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.39 |
| Forward PS | 3.69 |
| PB Ratio | 4.25 |
| P/TBV Ratio | 4.26 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.76 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.25, with a Debt / Equity ratio of 0.23.
| Current Ratio | 8.25 |
| Quick Ratio | 7.13 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.95 |
Financial Efficiency
Return on equity (ROE) is -22.09% and return on invested capital (ROIC) is -12.69%.
| Return on Equity (ROE) | -22.09% |
| Return on Assets (ROA) | -11.54% |
| Return on Invested Capital (ROIC) | -12.69% |
| Return on Capital Employed (ROCE) | -20.89% |
| Revenue Per Employee | $456,497 |
| Profits Per Employee | -$108,724 |
| Employee Count | 344 |
| Asset Turnover | 0.69 |
| Inventory Turnover | 1.46 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.40% in the last 52 weeks. The beta is 1.16, so SI-BONE's price volatility has been higher than the market average.
| Beta (5Y) | 1.16 |
| 52-Week Price Change | -17.40% |
| 50-Day Moving Average | 14.32 |
| 200-Day Moving Average | 14.34 |
| Relative Strength Index (RSI) | 60.44 |
| Average Volume (20 Days) | 319,693 |
Short Selling Information
The latest short interest is 1.13 million, so 2.69% of the outstanding shares have been sold short.
| Short Interest | 1.13M |
| Short Previous Month | 1.12M |
| Short % of Shares Out | 2.69% |
| Short % of Float | 3.05% |
| Short Ratio (days to cover) | 3.43 |
Income Statement
In the last 12 months, SI-BONE had revenue of $157.04 million and -$37.40 million in losses. Loss per share was -$0.91.
| Revenue | 157.04M |
| Gross Profit | 122.02M |
| Operating Income | -42.26M |
| Pretax Income | -40.85M |
| Net Income | -37.40M |
| EBITDA | -37.52M |
| EBIT | -42.26M |
| Loss Per Share | -$0.91 |
Full Income StatementBalance Sheet
The company has $150.82 million in cash and $38.54 million in debt, giving a net cash position of $112.28 million or $2.68 per share.
| Cash & Cash Equivalents | 150.82M |
| Total Debt | 38.54M |
| Net Cash | 112.28M |
| Net Cash Per Share | $2.68 |
| Equity (Book Value) | 164.97M |
| Book Value Per Share | 3.95 |
| Working Capital | 179.02M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$15.90 million and capital expenditures -$9.32 million, giving a free cash flow of -$25.22 million.
| Operating Cash Flow | -15.90M |
| Capital Expenditures | -9.32M |
| Free Cash Flow | -25.22M |
| FCF Per Share | -$0.60 |
Full Cash Flow StatementMargins
Gross margin is 77.70%, with operating and profit margins of -26.91% and -23.82%.
| Gross Margin | 77.70% |
| Operating Margin | -26.91% |
| Pretax Margin | -23.82% |
| Profit Margin | -23.82% |
| EBITDA Margin | -23.89% |
| EBIT Margin | -26.91% |
| FCF Margin | n/a |
Dividends & Yields
SI-BONE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.42% |
| Shareholder Yield | -11.42% |
| Earnings Yield | -5.32% |
| FCF Yield | -3.59% |
Analyst Forecast
The average price target for SI-BONE is $23.00, which is 37.23% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $23.00 |
| Price Target Difference | 37.23% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SI-BONE has an Altman Z-Score of 4.97 and a Piotroski F-Score of 2.
| Altman Z-Score | 4.97 |
| Piotroski F-Score | 2 |